#USA #San Diego #DermTech #Stratum #Smart Sticker

DermTech 2.0 Expands DermTech Stratum™

DermTech 2.0, a forefront company in precision dermatology, has announced an exciting development - the expansion of its non-invasive skin genomics service, DermTech Stratum™. This initiative is rooted in the company’s proprietary technology, the Smart Sticker®, which facilitates the collection of skin samples without the complications and invasiveness associated with traditional methods.

Overview of DermTech Stratum™

The enhanced DermTech Stratum™ service now offers comprehensive genomic and other analyses for samples obtained from both lesional and non-lesional skin. This is a crucial advancement for biopharmaceutical companies and researchers who are looking to delve deeper into the complexities of skin conditions and associated diseases.

One of the standout features of the new DermTech Stratum™ service is its extensive clinical tissue bank, which houses over 10,000 skin samples. These samples are collected non-invasively from individuals suffering from a variety of conditions, including:

• - Atopic dermatitis
• - Hidradenitis suppurativa
• - Vitiligo
• - Lupus
• - Psoriasis
• - Rheumatoid arthritis
• - Psoriatic arthritis
• - Skin cancers such as CTCL, BCC, SCC, and melanoma.

In addition, the tissue bank also comprises samples of actinic keratosis, lichenoid keratosis, and ichthyosis. With such a diverse range of conditions represented, DermTech Stratum™ is uniquely positioned to support research across various dermatological and oncological fields.

Supporting Drug Discovery and Clinical Research

The DermTech Stratum™ service is particularly crafted for indications where skin is either the primary target or a surrogate target organ. The platform supports drug discovery and development efforts focused on cancers and inflammatory diseases, making it a vital resource in clinical research studies. Currently, DermTech Stratum™ collaborates with over 30 pharmaceutical and research partners who rely on its capabilities for their development projects.

DermTech 2.0 President, Dr. Burkhard Jansen, expressed enthusiasm regarding the expansion: “We are excited to announce this next stage of DermTech Stratum services and believe the addition of clinical tissue bank samples offers an immense time and cost savings benefit to our customers.”

The Smart Sticker® Technology

The backbone of DermTech’s non-invasive approach lies in its Smart Sticker®, which measures 19mm in diameter and collects approximately 1.5mg of stratum corneum tissue. This method provides an effective alternative to surgical biopsies, which can be difficult to acquire and often painful for patients.

Once collected, samples are notably resilient; they do not require fixation or refrigeration and preserve genomic and proteomic materials from the skin at room temperature for up to 15 days. When stored at -80°C, these samples retain their integrity for over a year, providing researchers with the flexibility they need for their studies.

For those interested in exploring DermTech Stratum™ further, additional information can be found on the official website at DermTech Stratum.

In conclusion, DermTech 2.0 is setting new standards in dermatological research. With its advanced services and comprehensive resource offerings, it is empowering researchers and pharma partners to develop better, more effective treatments for a wide array of skin-related health challenges.